Oncology Medical Affairs Intern

Corcept Therapeutics

3 months ago

2.7 on Glassdoor

Redwood City, CA

Onsite

Internship

Trainee

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Medical Affairs Intern will support Corcept’s Medical Strategy team during a full-time summer internship, gaining exposure to the company’s oncology pipeline and clinical data. The role provides experience in medical content development, cross-functional collaboration, and insights generation to support product lifecycle management. Interns will participate in advisory board planning, congress activities, and deliver presentations as part of department and company-wide projects.

Skills

Qualifications

Pursuing Degree in Life Sciences or BusinessMinimum GPA 3.0Authorized to Work in the U.S.

About Corcept Therapeutics

corcept.com

Corcept Therapeutics is a biopharmaceutical company that discovers and develops medicines that modulate the glucocorticoid receptor to treat disorders driven by excess cortisol. The company commercialized Korlym (mifepristone) for hyperglycemia secondary to endogenous Cushing’s syndrome and is advancing next‑generation, selective GR modulators (for example, relacorilant) through clinical development. Corcept combines translational science, clinical trials, and commercial capabilities to target endocrine and oncology indications where cortisol signaling contributes to disease. The company is headquartered in Menlo Park, California.

Recent company news

GlobeNewswire

CORCEPT THERAPEUTICS INCORPORATED (CORT) SHAREHOLDER ALERT

8 hours ago

Business Wire

REMINDER: Corcept Therapeutics Incorporated Investors With Significant Losses Must Act By April 21, 2026

1 day ago

TipRanks

Corcept Therapeutics Lawsuit: CORT Investors Face Losses After FDA Rejection and Alleged Misleading Statements

7 hours ago

Financial Times

CORT Investors Have Opportunity to Lead Corcept Therapeutics Incorporated Securities Fraud Lawsuit with the Schall Law Firm – Company Announcement - FT.com

12 hours ago

ChartMill

Corcept Therapeutics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Corcept Therapeutics Incorporated - CORT

19 hours ago